TZH-15848-39704
3 vaccinations
7 coded responses
22 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 292 / SC
- Registered
- 2021-01-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-10
Registered in v-safe
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Significant lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body achesFree text: Severe cervical lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Unilateral severe lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Muscle or body achesFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Unilateral supraclavicular and axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-15
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Unilateral lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-01-31
- 2021-02-05
- 2021-02-14
- 2021-02-19
- 2021-03-08
- 2021-04-09
- 2021-07-09
-
2021-09-16
Dose 3 — Pfizer-BioNTech
- 2021-09-29
-
2021-09-30
Survey response — day 14, dose 3MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-12-18
- 2022-03-17
- 2022-09-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Significant lymphadenopathy
Systemic reaction (other): Severe cervical lymphadenopathy
Systemic reaction (other): Unilateral severe lymphadenopathy
Systemic reaction (other): Lymphadenopathy
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Unilateral supraclavicular and axillary lymphadenopathy
Release 2 — day 7, dose 2
Systemic reaction (other): Unilateral lymphadenopathy
Release 9 — day 14, dose 3
Symptoms: Congestion, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release